StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Summit Therapeutics Inc.
NasdaqGM:SMMT
Sector
Location
Market Cap
USD 20.80 B
Share Price
USD 28.01
Avg Daily Volume
5,229,793
Change (1 day)
5.54%
Change (1 year)
177.60%
Change (YTD)
56.92%
Summit Therapeutics Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: -70.50%
Summit Therapeutics Inc. Return on Equity (ROE) is -70.50% for the Trailing 12 Months (TTM) ending March 31, 2025. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
-
Summit Therapeutics Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was -539.47%, a 446.62% change year over year.
-
Summit Therapeutics Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was -98.69%, a -10.35% change year over year.
-
Summit Therapeutics Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was -110.08%.
Competitors
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
Novartis AG
USD 117.27
NOVN.SW
+1.11
0.95%
Abbott Laboratories
USD 125.83
ABT
+0.10
0.08%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Vertex Pharmaceuticals Incorporated
USD 476.95
VRTX
+6.82
1.45%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Bristol-Myers Squibb Company
USD 48.98
BMY
+0.96
2.00%
CSL Limited
USD 178.31
CSL.AX
+3.04
1.74%
Chugai Pharmaceutical Co., Ltd.
USD 49.58
4519.T
+1.01
2.08%
GSK plc
USD 18.62
GSK.L
+0.40
2.17%
Regeneron Pharmaceuticals, Inc.
USD 572.39
REGN
+11.46
2.04%
MERCK Kommanditgesellschaft auf Aktien
USD 132.14
MRK.DE
+4.08
3.19%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.97
600276.SS
-0.01
-0.09%
Takeda Pharmaceutical Company Limited
USD 29.83
4502.T
+0.18
0.60%
Key Data
| Date | Return on Equity (ROE) | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share |
|---|
Competitors
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
Novartis AG
USD 117.27
NOVN.SW
+1.11
0.95%
Abbott Laboratories
USD 125.83
ABT
+0.10
0.08%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Vertex Pharmaceuticals Incorporated
USD 476.95
VRTX
+6.82
1.45%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Bristol-Myers Squibb Company
USD 48.98
BMY
+0.96
2.00%
CSL Limited
USD 178.31
CSL.AX
+3.04
1.74%
Chugai Pharmaceutical Co., Ltd.
USD 49.58
4519.T
+1.01
2.08%
GSK plc
USD 18.62
GSK.L
+0.40
2.17%
Regeneron Pharmaceuticals, Inc.
USD 572.39
REGN
+11.46
2.04%
MERCK Kommanditgesellschaft auf Aktien
USD 132.14
MRK.DE
+4.08
3.19%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.97
600276.SS
-0.01
-0.09%
Takeda Pharmaceutical Company Limited
USD 29.83
4502.T
+0.18
0.60%